SARS-CoV-2 Spike Protein Mutations in Different Variants: A Comparison Between Vaccinated and Unvaccinated Population in Western Amazonia.
SARS-CoV-2
mutations
sequences
vaccination
variants
Journal
Bioinformatics and biology insights
ISSN: 1177-9322
Titre abrégé: Bioinform Biol Insights
Pays: United States
ID NLM: 101467187
Informations de publication
Date de publication:
2023
2023
Historique:
received:
01
04
2023
accepted:
18
06
2023
medline:
18
7
2023
pubmed:
18
7
2023
entrez:
18
7
2023
Statut:
epublish
Résumé
The increased transmissibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has generated variants of concern (VOCs) throughout the pandemic, responsible for waves of cases worldwide. To monitor mutations in the S gene of SARS-CoV-2 in different variants, we evaluated 1497 individuals with COVID-19 in western Amazonia in the period April 2021 to July 2022. The epidemiological and clinical data of the individuals were collected; subsequently, the samples were extracted using a commercial kit, the viral load was assessed, and viral genomes were sequenced. We analyzed the quality and mutations of the genomes and maximum likelihood phylogenetic inference. However, 3 main clusters were observed, referring to Gamma (52.91%), Delta (24.38%), and Omicron (20.38%) VOCs with wide distribution in all health regions of the Rondônia state. Regarding the vaccination profile, there was a higher percentage of unvaccinated and partially vaccinated individuals, with more representatives by the Gamma variant. A total of 1412 sequences were suitable for mutation analysis in the S gene region. The Omicron VOC showed 38 mutations, with the Delta and Gamma variants with 16 and 17, respectively. The VOC Omicron and Gamma shared 4 mutations E484K, H655Y, N501Y, and N679K with high frequency, and Delta and Omicron 2 mutations (T478K and T95I). Regarding the comparison between the frequency of mutations for each variant concerning the vaccination groups, there were no changes in mutations for each group. In conclusion, the study showed a temporal increase in mutations and subvariants for characterized strains. Furthermore, the vaccination profile did not impact significant changes in the mutational profile yet remains a determining factor for severe disease.
Identifiants
pubmed: 37461740
doi: 10.1177/11779322231186477
pii: 10.1177_11779322231186477
pmc: PMC10350575
doi:
Types de publication
Journal Article
Langues
eng
Pagination
11779322231186477Informations de copyright
© The Author(s) 2023.
Déclaration de conflit d'intérêts
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
Cell. 2021 May 27;184(11):2939-2954.e9
pubmed: 33852911
Appl Microbiol Biotechnol. 2021 Dec;105(24):9035-9045
pubmed: 34755213
JAMA. 2022 Feb 15;327(7):639-651
pubmed: 35060999
Clin Pract. 2021 Oct 21;11(4):778-784
pubmed: 34698149
ACS Infect Dis. 2022 Mar 11;8(3):546-556
pubmed: 35133792
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
iScience. 2022 Apr 15;25(4):104156
pubmed: 35368908
J Phys Chem Lett. 2021 Dec 16;12(49):11850-11857
pubmed: 34873910
Expert Rev Vaccines. 2021 Oct;20(10):1201-1209
pubmed: 34488546
Cell Rep Med. 2020 Sep 22;1(6):100098
pubmed: 32904687
Lancet. 2021 Jan 9;397(10269):72-74
pubmed: 33306990
Nat Methods. 2017 Jun;14(6):587-589
pubmed: 28481363
J Med Virol. 2022 May;94(5):1825-1832
pubmed: 35023191
China CDC Wkly. 2021 Dec 3;3(49):1049-1051
pubmed: 34934514
J Med Virol. 2022 Apr;94(4):1255-1256
pubmed: 34850421
Nature. 2022 Aug;608(7923):593-602
pubmed: 35714668
N Engl J Med. 2022 Apr 21;386(16):1532-1546
pubmed: 35249272
MedComm (2020). 2021 Dec 16;2(4):838-845
pubmed: 34957469
Sci Total Environ. 2020 Nov 20;744:140911
pubmed: 32693284
Int J Infect Dis. 2021 Mar;104:373-378
pubmed: 33434663
Ann Intern Med. 2021 Feb;174(2):JC15
pubmed: 33524290
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Cell Host Microbe. 2021 May 12;29(5):747-751.e4
pubmed: 33887205
Science. 2021 May 21;372(6544):815-821
pubmed: 33853970
Cell Mol Immunol. 2022 Nov;19(11):1302-1310
pubmed: 36224497
PLoS Pathog. 2022 Feb 17;18(2):e1010260
pubmed: 35176090
Hum Vaccin Immunother. 2022 Nov 30;18(5):2068883
pubmed: 35507895
Virus Evol. 2022 Mar 18;8(1):veac024
pubmed: 35371559
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
J Med Virol. 2022 Jul;94(7):2969-2976
pubmed: 35246846
Nat Med. 2021 Jul;27(7):1230-1238
pubmed: 34035535
BMJ. 2021 Nov 29;375:n2943
pubmed: 34845008
Microbiol Spectr. 2022 Feb 23;10(1):e0236621
pubmed: 35196783
Mem Inst Oswaldo Cruz. 2023 Jan 20;117:e220155
pubmed: 36700580
Brief Bioinform. 2019 Jul 19;20(4):1160-1166
pubmed: 28968734
Hum Vaccin Immunother. 2022 Nov 30;18(6):2096970
pubmed: 35878789
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Virus Res. 2014 Dec 19;194:90-9
pubmed: 25451065